Additionally, IHC analysis with the proliferation marker Ki-67 revealed that combination drug treatment effectively inhibited cancer cell growth, while single drug treatment only had a marginal effect on cell proliferation, consistent with tumor growth over time (Fig 7B). The gene discussed is MKI67; the disease is neoplasm.